LONAPEGSOMATROPIN ASCENDIS PHARMA
3MG INJ PSO LQF 4X3MG+4X0,279ML+6J
| SÚKL code | 0255440 |
|---|---|
| Name of the product | LONAPEGSOMATROPIN ASCENDIS PHARMA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | LONAPEGSOMATROPIN ASCENDIS PHARMA |
| Supplement | 3MG INJ PSO LQF 4X3MG+4X0,279ML+6J |
| Strenght | 3MG |
| Pharmaceutical form | Powder and solvent for solution for injection |
| Package | 4X3MG+4X0,279ML+6J |
| Route | Subcutaneous use |
| Wrap type | Cartridge |
| Legal status | na lékařský předpis |
| Active substance |
SOMATOTROPIN (SOMATOTROPINUM) LONAPEGSOMATROPIN (LONAPEGSOMATROPINUM) |
| ATC group | H01AC |
| ATC group name | SOMATROPIN A AGONISTÉ SOMATROPINU |
| Doping | Hormony, růstové faktory a příbuzné látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | EU/1/21/1607/001 |
|---|---|
| Type of MA | Orphan medicinal products |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Ascendis Pharma Endocrinology Division A/S, Hellerup |
| MA Holder country | DÁNSKO |
cz